Table 1 Subject cohorts details.
From: SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
Pediatric COVID-19 | Adult COVID-19 | Negative | ||||||
|---|---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | ||||||
Patients | Samples | 254 | 71 | 48 | ||||
Individuals | 122 | 71 | 48 | |||||
Symptoms | Asymptomatic | 44 (36%) | 10 (14%) | – | ||||
Mild | 78 (64%) | 50 (70.5%) | – | |||||
Severe | 0 | 11 (15.5%) | ||||||
Age | Mean±stdev | 10.8 ± 4.9 years | Mean ± stdev | 43.7 ± 19.3 years | Mean ± stdev | – | ||
0–8 years | 45 (37%) | Median | 45 | Adults (N = 28) | 18–65 | |||
8–12 years | 33 (27%) | Min | 18 | Pediatrics (N = 20) | 11–18 | |||
12–18 years | 44 (36%) | Max | 84 | |||||
Sex | Female | 49 (40%) | 34 (48%) | – | ||||
Male | 73 (60%) | 37 (52%) | – | |||||
